APA (7th ed.) Citation

R, C., LMI, J., MD, V., B, R., R, B., G, F., . . . M, F. (2026). Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: A multicenter retrospective landmark analysis. International urology and nephrology, 58(7), 2463. https://doi.org/10.1007/s11255-025-04946-9

Chicago Style (17th ed.) Citation

R, Contieri, et al. "Defining the Optimal Duration of Maintenance Mitomycin C in Intermediate-risk Ta NMIBC: A Multicenter Retrospective Landmark Analysis." International Urology and Nephrology 58, no. 7 (2026): 2463. https://doi.org/10.1007/s11255-025-04946-9.

MLA (9th ed.) Citation

R, Contieri, et al. "Defining the Optimal Duration of Maintenance Mitomycin C in Intermediate-risk Ta NMIBC: A Multicenter Retrospective Landmark Analysis." International Urology and Nephrology, vol. 58, no. 7, 2026, p. 2463, https://doi.org/10.1007/s11255-025-04946-9.